Prevention of hip fractures: Drug therapy

Bone

Volumn 18, Issue 3 SUPPL., 1996, Pages S159-S163

  Lips, P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bisphosphonates; Calcium and vitamin D; Hip fractures; Hormone replacement; Prevention

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; CLODRONIC ACID; ESTROGEN; ETIDRONIC ACID; GESTAGEN; PAMIDRONIC ACID; RALOXIFENE; TAMOXIFEN; VITAMIN D;

BLEEDING; BONE ATROPHY; BONE MASS; BREAST CANCER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ESTROGEN THERAPY; GALLBLADDER DISEASE; GASTROINTESTINAL SYMPTOM; HIP FRACTURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUPUS ERYTHEMATOSUS; META ANALYSIS; NURSING HOME; OSTEOMALACIA; PUBLIC HEALTH; RISK; RISK FACTOR;

AGED; AGED, 80 AND OVER; BONE DENSITY; BONE RESORPTION; CALCIUM; DIPHOSPHONATES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS; VITAMIN D;

EID: 0029929627     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(95)00497-1     Document Type: Article

References (46)

1. Balena, R., Toolan, B. C., Shen, M., et al. The effects of 2 year treatment with the amino-bisphosphonate alendronate on bone metabolism, bone histomorphometry and bone strength in ovariectomized non-human primates. J Clin Invest 92:2577-2586; 1993.
2. Belchetz, P. E. Hormonal treatment of postmenopausal women. N Engl J Med 330:1062-1071; 1994.
3. Bergkvist, I., Adami, H. O., Persson, L., Hoover, R., and Schairer, C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 321:293-297; 1989.
4. Black, D. M. Why elderly women should be screened and treated to prevent osteoporosis. Am J Med 98:67S-75S; 1995.
5. Black, L. J., Sato, M., and Rowley, E. R. Raloxifene prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 93:63-69; 1994.
6. Cauley, J. A., Seeley, D. G., Ensrud, K., Ettinger, B., Black, D., and Cummings, S. R. Estrogen replacement therapy and fractures in older women. Ann Intern Med 122:9-16; 1995.
7. Chapuy, M. C., Arlot, M. E., Delmas, P. D., and Meunier, P. J. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 308:1081-1082; 1994.
8. Chapuy, M. C., Arlot, M. E., Duboeuf, F., Brun, J., Crouzet, B., Arnaud, S., Delmas, P. D., and Meunier, P. J. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637-1642; 1992.
9. Chesnut, C., McClung, M. R., Ensrud, K. E., et al. Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling. Am J Med 99:144-152; 1995.
10. Colditz, G. A., Hankinson, S. E., Hunter, D. J., et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332:1589-1593; 1995.
11. Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646-650; 1993.
12. Cummings, S. R., Black, D. M., Nevitt, M. C., et al. Bone density at various sites for prediction of hip fractures. Lancet 341:72-75; 1993.
13. Dawson-Hughes, B., Dallal, G. E., Krall, E. A., Harris, S., Sokoll, L. I., and Falconer, G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 115:505-512; 1991.
14. Dawson-Hughes, B., Dallal, G. E., Krall, E. A., Sadowski, L., Sahyoun, N., and Tannenbaum, S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323:878-883; 1990.
15. Elders, P. J. M., Lips, P., Netelenbos, J. C., et al. Long-term effect of calcium supplementation on bone loss in perimenopausal women. J Bone Miner Res 9:963-970; 1994.
16. Felson, D. T., Zhang, Y., Hannon, M. T., Kiel, D. P., Wilson, P. W., and Anderson, J. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 329:1141-1146; 1993.
17. Fillipponi, P., Pedetti, M., Fedeli, L., et al. Cyclical clodronate is effective in preventing postmenopausal bone loss: A comparative study with transcutaneous hormone replacement therapy. J Bone Miner Res 10:697-703; 1995.
18. Fox, K. M., Tobin, J. D., and Plato, C. C. Longitudinal study of bone loss in the second metacarpal. Calcif Tissue Int 39:218-225; 1986.
19. Grady, D., Rubin, S. M., Petitti, D. B., et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037; 1992.
20. Harris, S. T., Watts, N. B., Jackson, R. D., et al. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy. Am J Med 95:557-567; 1993.
21. Heikinheimo, R. J., Inkovaara, J. A., Harju, E. J., Haavisto, M. V., Kaarela, R. H., Kataja, J. M., Kokko, A. M. L., Kolho, L. A., and Rajala, S. A. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 51:105-110; 1992.
22. Jones, G., Nguyen, T., Sambrook, P., Kelly, P. J., and Eisman, J. A. Progressive loss of bone in the femoral neck of elderly people: Longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ 309:691-695; 1994.
23. Kanis, J. A. Treatment of osteoporosis in elderly women. Am J Med 98:60S-66S; 1995.
24. Kanis, J. A., Johnell, O., Gullberg, B., et al. Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ 305:1124-1128; 1992.
25. Lafferty, E. W. Postmenopausal estrogen replacement: A long-term cohort study. Am J Med 97:66-77; 1994.
26. Lips, P., Graafmans, W. C., Ooms, M. E., Bezemer, P. D., and Bouter, L. M. The effect of vitamin D supplementation on the incidence of hip fractures in elderly people. J Bone Miner Res 9:S148; 1994 (abstr).
27. Lips, P., Chapuy, M. C., Dawson-Hughes, B., and Pols, H. A. P. International comparison of serum 25-hydroxyvitamin D measurements. J Bone Miner Res 10:S496; 1995.
28. Lips, P. and Obrant, K. The pathogenesis and treatment of hip fractures. Osteoporosis Int 1:218-231; 1991.
29. Lips, P., van Ginkel, E. C., Jongen, M. J. M., Rubertus, A., van der Vijgh, W. J. F., and Netelenbos, J. C. Determinants of vitamin D status in patients with hip fracture and elderly control subjects. Am J Clin Nutr 46:1005-1010; 1987.
30. Lips, P., Wiersinga, A., van Ginkel, F. C., Jongen, M. I. M., Netelenbos, J. C., Hackeng, W. H. L., Delmas, P. D., and van der Vijgh, W. J. F. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 67:644-650; 1988.
31. Love, R. R., Mazess, R. B., Barden, H. S., et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326:852-856; 1992.
32. McKenna, M. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93:69-77; 1992.
33. Ooms, M. E., Lips, P., Roos, J. C., van der Vijgh, W. J. F., Popp-Snijders, C., Bezemer, P. D., and Bouter, L. M. Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10:1177-1184; 1995.
34. Ooms, M. M., Roos, J. C., Bezemer, P. D., van der Vijgh, W. J. F., Bouter, L. M., and Lips, P. Prevention of bone loss by vitamin D supplementation in elderly women: A randomized double-blind trial. J Clin Endocrinol Metab 80:1052-1058; 1995.
35. Parfitt, A. M. Morphological basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis. Miner Electrolyte Metab 4:273-287; 1980.
36. Prince, R. L., Smith, M., Dick, I. M., et al. Prevention of postmenopausal osteoporosis: A comparative study of exercise, calcium supplementation, and hormone replacement therapy. N Engl J Med 325:1189-1195; 1991.
37. Quigley, M. E., Martin, P. L., Burnier, A. M., and Brooks, P. Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 156:1516-1523; 1987.
38. Recker, R. R., Karpf, D. B., Quan, H., et al. Three-year treatment of osteoporosis with alendronate: Effect on vertebral fracture incidence. Endocrine Meeting; 1995. Bethesda, MD: Endocrine Society Press; 1995; 49.
39. Reid, I. R., Ames, R. W., Evans, M. C., Gamble, G. D., and Sharpe, S. J. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: A randomized controlled trial. Am J Med 98:331-335; 1995.
40. Sanchez-Guerrero, J., Liang, M. H., Karlson, E. W., Hunter, D. J., and Colditz, G. A. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythermatosus. Ann Intern Med 122:430-433; 1995.
41. Shaprio, D. R., Thompson, D. E., Karpf, D. B., et al. Non-vertebral fracture incidence in patients treated with alendronate. J Bone Miner Res 10:S176; 1995 (abstr.).
42. Stampfer, M. J., Colditz, G. A., Willett, W. C., et al. Postmenopausal estrogen therapy and cardiovascular disease - ten year follow-up from the Nurses' Health Study. N Engl J Med 325:756-762; 1991.
43. Tilyard, M., Spears, G. F. S., Thomson, J., and Dovey, S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326:357-362; 1992.
44. Torgerson, D. J. and Kanis, J. A. Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium. Q J Med 88:135-139; 1995.
45. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843, World Health Organization on Geneva; 1-127; 1994.
46. Wimalawansa, S. J. Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: Four year randomized study. Am J Med 99:36-42; 1995.